Glucagon-like peptide 1 stimulates insulin secretion via inhibiting RhoA/ROCK signaling and disassembling glucotoxicity-induced stress fibers
At the end of week 120, the participants who received semaglutide regained 11.6 percentage points of lost weight compared to 1.9 percentage points in the placebo group
Efficacy and Safety of Dulaglutide Monotherapy Compared With Glimepiride in East-Asian Patients With Type 2 Diabetes in a Multicentre, Double-Blind, Randomized, Parallel-Arm, Active Comparator, Phase III Trial
These supplements support the process but do not replace the medication is core effects
No events were reported by patients receiving placebo
Extended Data Figure 9 The R176Q mutation decreases the potency of GLP-1R, but does not affect its binding capacity with GLP-1